Multifocal Primary Uveal Melanoma: Clinical and Molecular Characteristics.

Choroidal nevus malignant transformation Germline BAP1 mutation Iodine-125 plaque brachytherapy Multifocal uveal melanoma

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 30 11 2017
revised: 29 01 2018
entrez: 25 1 2019
pubmed: 25 1 2019
medline: 25 1 2019
Statut: ppublish

Résumé

We report two patients who developed a second distinct choroidal melanoma in the same eye following successful regression of their first choroidal melanoma after iodine-125 plaque brachytherapy. Neither patient demonstrated ocular melanocytosis, local tumor recurrence, or vitreous seeding. One patient had the second tumor arising from a previously documented choroidal nevus, and after undergoing enucleation, there was no detectable connection between the tumors on histopathologic examination. Germline

Identifiants

pubmed: 30675471
doi: 10.1159/000487891
pii: oop-0005-0008
pmc: PMC6341333
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8-12

Références

Arch Ophthalmol. 1999 Feb;117(2):255-8
pubmed: 10037575
Ophthalmology. 1999 Jul;106(7):1345-8
pubmed: 10406619
Klin Monbl Augenheilkd. 2001 Sep;218(9):626-31
pubmed: 11590472
Am J Ophthalmol. 2001 Dec;132(6):941-3
pubmed: 11730671
Surv Ophthalmol. 2002 Jan-Feb;47(1):36-41
pubmed: 11801268
Arch Ophthalmol. 2002 Aug;120(8):1090-1
pubmed: 12149066
Invest Ophthalmol Vis Sci. 2003 Feb;44(2):458-62
pubmed: 12556369
Ophthalmology. 2005 Oct;112(10):1784-9
pubmed: 16154197
Graefes Arch Clin Exp Ophthalmol. 2011 Jan;249(1):141-4
pubmed: 20853114
Science. 2010 Dec 3;330(6009):1410-3
pubmed: 21051595
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
Nat Genet. 2011 Aug 28;43(10):1018-21
pubmed: 21874003
J Med Genet. 2011 Dec;48(12):856-9
pubmed: 21941004
Am J Hum Genet. 2013 Jun 6;92(6):974-80
pubmed: 23684012
Semin Ophthalmol. 2014 May;29(3):163-5
pubmed: 23869977
Retin Cases Brief Rep. 2017 Spring;11(2):131-133
pubmed: 27096381
Retin Cases Brief Rep. 2018 Winter;12(1):1-4
pubmed: 27749792
Am J Ophthalmol. 2017 May;177:9-16
pubmed: 28163118
Br J Ophthalmol. 1978 Jun;62(6):408-13
pubmed: 666990
Ophthalmology. 1983 Dec;90(12):1472-6
pubmed: 6677847
Ophthalmology. 1982 Aug;89(8):953-60
pubmed: 7133641
N Engl J Med. 1977 Mar 17;296(11):634-5
pubmed: 840250
Arch Ophthalmol. 1977 Apr;95(4):617-23
pubmed: 849184
Ophthalmology. 1996 Feb;103(2):256-62
pubmed: 8594511
Ophthalmology. 1998 Jan;105(1):195-8
pubmed: 9442799
Arch Ophthalmol. 1998 May;116(5):694-5
pubmed: 9596516

Auteurs

Jose J Echegaray (JJ)

Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Carlos A Medina (CA)

Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Charles V Biscotti (CV)

Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Thomas Plesec (T)

Department of Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Arun D Singh (AD)

Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Classifications MeSH